Behavioral Treatments for Anxiety and Depression in Veterans With Parkinson's Disease



Status:Completed
Conditions:Anxiety, Depression, Parkinsons Disease
Therapuetic Areas:Neurology, Psychiatry / Psychology
Healthy:No
Age Range:18 - Any
Updated:3/30/2013
Start Date:November 2011
End Date:October 2012
Contact:Jessica S Calleo, PhD
Email:jessica.calleo@va.gov
Phone:713-794-8521

Use our guide to learn which trials are right for you!

Increasing Access and Implementation of Behavioral Treatments for Anxiety and Depression in Rural Veterans With Parkinson's Disease


Behavioral Treatments for Anxiety and Depression (BehTA-D) is a research study for anxiety
and depression in individuals with Parkinson's disease (PD). The research clinicians try to
teach skills that may help participants cope with anxiety and depression in the context of
Parkinson's disease. Research clinicians will also discuss ways improve management of
Parkinson's symptoms. Other skills taught include how to relax, change thinking, add in
meaningful pleasant activity.


Components of evidence-based cognitive behavioral therapy (CBT) treatments from current
manuals developed for depression and anxiety will be used to construct the 8-week treatment
program. The flexibility of modular based treatment allows patients and counselors to
personalize interventions and skills for managing anxiety and depressive symptoms. The first
treatment session will be in-person. All following sessions will be provided by telephone.
Caregivers will have the option of being involved in 2 ways throughout treatment - as a
"coach" to facilitate use of new skills by their loved one with PD and as a recipient of
stress- management support. The scope of caregiver involvement will vary across patients,
based on their preference. Involved caregivers will be given the opportunity to participate
in 1 telephone-based stress-management session and 1 follow-up call scheduled individually
during the first 4 weeks of treatment.

Inclusion Criteria:

1. Have a confirmed diagnosis of idiopathic Parkinson's disease

2. Have significant anxiety and/or depressive symptoms as indicated by a score of
greater than 4 on the Geriatric Depression Scale -15 or greater than 5 on the
Hospital Anxiety and Depression anxiety subscale

Exclusion Criteria:

Patients will be excluded if they have cognitive impairment as indicated by the Montreal
Cognitive Assessment (MoCA < 23) or if they have a condition that threatens their safety
or life including suicidal intent, current psychosis, bipolar, substance abuse or impulse
control disorders within the past month.
We found this trial at
1
site
?
mi
from
Houston, TX
Click here to add this to my saved trials